Prediction of genetic subgroups in adult supra tentorial gliomas by pre- and intraoperative parameters

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

(2016) David N. Louis et al.   ACTA NEUROPATHOLOGICA

Pre- and Posttreatment Glioma: Comparison of Amide Proton Transfer Imaging with MR Spectroscopy for Biomarkers of Tumor Proliferation

(2016) Ji Eun Park et al.   RADIOLOGY

Mutational landscape and clonal architecture in grade II and III gliomas

(2015) Hiromichi Suzuki et al.   NATURE GENETICS

Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas

(2015)   NEW ENGLAND JOURNAL OF MEDICINE

Cell cycle progression is an essential regulatory component of phospholipid metabolism and membrane homeostasis

(2015) Miguel Sanchez-Alvarez et al.   Open Biology

PCR-Based Simple Subgrouping Is Validated for Classification of Gliomas and Defines Negative Prognostic Copy Number Aberrations in IDH Mutant Gliomas

(2015) Shunsuke Nakae et al.   PLoS One

Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas

(2015) Yuchen Jiao et al.   Oncotarget

Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas

(2015) Patrick J. Killela et al.   Oncotarget

IDH1 R132H Mutation Generates a Distinct Phospholipid Metabolite Profile in Glioma

(2014) Morteza Esmaeili et al.   CANCER RESEARCH

Clinical Proton MR Spectroscopy in Central Nervous System Disorders

(2014) Gülin Öz et al.   RADIOLOGY

Subgrouping of gliomas on the basis of genetic profiles

(2013) Yuichi Hirose et al.   Brain Tumor Pathology

H3F3A K27M mutations in thalamic gliomas from young adult patients

(2013) Koki Aihara et al.   NEURO-ONCOLOGY

Radiological features of supratentorial gliomas are associated with their genetic aberrations

(2013) Yuya Nishiyama et al.   NEUROSURGICAL REVIEW

5-Aminolevulinic Acid Induced Fluorescence Is a Powerful Intraoperative Marker for Precise Histopathological Grading of Gliomas with Non-Significant Contrast-Enhancement

(2013) Georg Widhalm et al.   PLoS One

Magnetic resonance spectroscopy metabolite profiles predict survival in paediatric brain tumours

(2012) Martin Wilson et al.   EUROPEAN JOURNAL OF CANCER

Whole Genome Analysis From Microdissected Tissue Revealed Adult Supratentorial Grade II-III Gliomas Are Divided Into Clinically Relevant Subgroups by Genetic Profile

(2011) Yuichi Hirose et al.   NEUROSURGERY

Rosette-forming glioneuronal tumor: a pineal region case with IDH1 and IDH2 mutation analyses and literature review of 43 cases

(2010) Orestes E. Solis et al.   JOURNAL OF NEURO-ONCOLOGY

IDH1 Mutations Are Early Events in the Development of Astrocytomas and Oligodendrogliomas

(2009) Takuya Watanabe et al.   AMERICAN JOURNAL OF PATHOLOGY

High Incidence of Protein-Truncating TP53 Mutations in BRCA1-Related Breast Cancer

(2009) H. Holstege et al.   CANCER RESEARCH

IDH1andIDH2Mutations in Gliomas

(2009) Hai Yan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Detection of the DNA Point Mutation of Colorectal Cancer Cells Isolated from Feces Stored Under Different Conditions

(2008) Y. Koga et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Role of Extent of Resection in the Long-Term Outcome of Low-Grade Hemispheric Gliomas

(2008) Justin S. Smith et al.   JOURNAL OF CLINICAL ONCOLOGY

An Integrated Genomic Analysis of Human Glioblastoma Multiforme

(2008) D. W. Parsons et al.   SCIENCE